Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
Status:
Completed
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, multi-center, parallel-group study designed to compare
the safety and efficacy of a range of doses of ZP-Zolmitriptan intracutaneous microneedle
systems to placebo.